TSPYL2 Reduced Gefitinib Resistance and DNA Damage Repair Via Suppressing SIRT1-Mediated FOXO3 Deacetylation
- 22 February 2022
- journal article
- research article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 14 (6) , 407-419
Abstract
Background: Colorectal cancer (CRC) is a malignancy with high mortality. TSPYL2 participates in tumor suppression but its role in CRC remains unknown. Methodology & results: TSPYL2 was downregulate...Keywords
This publication has 24 references indexed in Scilit:
- TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate CancerClinical Pharmacology & Therapeutics, 2017
- The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3Oncogene, 2016
- TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activationCell Death & Differentiation, 2015
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trialThe Lancet Oncology, 2014
- SIRT1 and other sirtuins in metabolismTrends in Endocrinology & Metabolism, 2014
- Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradationOncogene, 2011
- Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2Cell, 2011
- TSPYL2 Is Important for G1 Checkpoint Maintenance upon DNA DamagePLOS ONE, 2011
- Differentially expressed nucleolar transforming growth factor-β1 target (DENTT) exhibits an inhibitory role on tumorigenesisCarcinogenesis, 2008
- Epigenomic Profiling Reveals Novel and Frequent Targets of Aberrant DNA Methylation-Mediated Silencing in Malignant GliomaCancer Research, 2006